Dr. S. Vincent Rajkumar on a New Bortezomib Triplet in Multiple Myeloma
Published: | Updated:
S. Vincent Rajkumar, MD, discusses bortezomib, lenalidomide, and dexamethasone coming out on top in a recent phase III trial over lenalidomide and dexamethasone alone.
